Status:
COMPLETED
The Urinary Microbiome in Patients Receiving Intradetrusor Botox Injections
Lead Sponsor:
MetroHealth Medical Center
Conditions:
Overactive Bladder
Eligibility:
FEMALE
18-89 years
Brief Summary
An altered urinary microbiome (UM) may explain the symptoms in overactive bladder (OAB) patients who were previously considered to have "idiopathic" OAB. To date, most research on the relationship bet...
Eligibility Criteria
Inclusion
- \- Women undergoing intradetrusor botox injection with botox 100 U
Exclusion
- Current UTI
- History of recurrent UTI
- History of antibiotic exposure for any reason (including if response is "unknown")
- Antibiotic exposure for any reason other than post-procedure prophylaxis during the four-week follow-up period.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04479709
Start Date
January 1 2021
End Date
June 30 2022
Last Update
February 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MetroHealth
Cleveland, Ohio, United States, 44109